Page last updated: 2024-08-26

mizoribine and Experimental Mammary Neoplasms

mizoribine has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koyama, H; Tsuji, M	1

Other Studies

1 other study(ies) available for mizoribine and Experimental Mammary Neoplasms

Article	Year
Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells. Biochemical pharmacology, 1983, Dec-01, Volume: 32, Issue:23 Topics: Adenine Phosphoribosyltransferase; Adenosine; Adenosine Kinase; Animals; Biotransformation; Cell Line; Cell Survival; Drug Resistance; Hypoxanthine Phosphoribosyltransferase; IMP Dehydrogenase; Ketone Oxidoreductases; Mammary Neoplasms, Experimental; Mice; Mutation; Phosphorylation; Ribonucleosides	1983

Article

Year

Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells.

Biochemical pharmacology, 1983, Dec-01, Volume: 32, Issue:23

Topics: Adenine Phosphoribosyltransferase; Adenosine; Adenosine Kinase; Animals; Biotransformation; Cell Line; Cell Survival; Drug Resistance; Hypoxanthine Phosphoribosyltransferase; IMP Dehydrogenase; Ketone Oxidoreductases; Mammary Neoplasms, Experimental; Mice; Mutation; Phosphorylation; Ribonucleosides

1983